Valerenic acid
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Valerenic acid | |
|---|---|
| Image:ValerenicAcid2d.png | |
| Image:ValerenicAcid3d.png | |
| IUPAC name | (E)-3-[(4S,7R,7aR)-3,7-dimethyl- 2,4,5,6,7,7a-hexahydro- 1H-inden-4-yl]- 2-methylprop-2-enoic acid |
| Identifiers | |
| CAS number | |
| PubChem | |
| SMILES | CC1CCC(C2=C(CCC12)C)C=C(C)C(=O)O |
| Properties | |
| Molecular formula | C15H22O2 |
| Molar mass | 234.334 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
Valerenic Acid is a constituent of the essential oil of the Valerian plant.
Valerian is used as a herbal sedative which may be helpful in the treatment of insomnia. While the precise mechanism of this action has not been established and it is likely that several different components of the plant contribute to the effect, valerenic acid is thought to be at least partly responsible for the sedative effects.
Valerenic acid has been demonstrated to be both a subtype-selective GABAA agonist[1] acting mainly at α1β2 and α1β3 subtypes,[2] and also a 5HT5A partial agonist.[3] Both of these actions are likely to play a role in the sedative effects of this compound, as other GABAA agonists such as benzodiazepines are commonly used as sedative drugs, and while no selective 5HT5A agonists are currently used medically, the 5HT5A receptor is known to be highly expressed in the suprachiasmatic nucleus of the brain, which is believed to be involved in the sleep-wake cycle.
Valerenic acid has also been reported to be an NF-κB inhibitor, and may be partly responsible for the reported anti-inflammatory action of the valerian plant.[4]
References
- ↑ Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesthesia and Analgesia. 2004 Feb;98(2):353-8.
- ↑ Khom S, Baburin I, Timin E, Hohaus A, Trauner G, Kopp B, Hering S. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology. 2007 Jul;53(1):178-87.
- ↑ Dietz BM, Mahady GB, Pauli GF, Farnsworth NR. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Research. Molecular Brain Research. 2005 Aug 18;138(2):191-7.
- ↑ Jacobo-Herrera NJ, Vartiainen N, Bremner P, Gibbons S, Koistinaho J, Heinrich M. NF-kappaB modulators from Valeriana officinalis. Phytotherapy Research. 2006 Oct;20(10):917-9.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
